Net Asset Value(s)

Click here - to use the wp menu builder

News Room

Less than 1 min.Read

Net Asset Value(s)

By Investing Today

February 27, 2025

Octopus AIM VCT 2 plc

Net Asset Value

Octopus AIM VCT 2 plc announces that as at 24 February 2025 the unaudited net asset value of the Ordinary shares was approximately 39.2 pence per share.

For further information, please contact:

Rachel Peat
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Net Asset Value(s)

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 27 February 2025

Black Hills Corp. Announces Upcoming Investor Meetings

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

Ultimovacs ASA: Approval and publication of prospectus

Global Water Resources Declares Monthly Dividend

SUNation Energy Announces Initial Closing of Registered Direct Offering Generating Gross Proceeds of $15 Million

Topics

Black Hills Corp. Announces Upcoming Investor Meetings

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

Ultimovacs ASA: Approval and publication of prospectus

Global Water Resources Declares Monthly Dividend

SUNation Energy Announces Initial Closing of Registered Direct Offering Generating Gross Proceeds of $15 Million

Cibus Announces Leadership Change and CEO Succession Plan

Astrotech Creates New Subsidiary EN-SCAN, Inc.

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval

Related Articles

Black Hills Corp. Announces Upcoming Investor Meetings

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

Ultimovacs ASA: Approval and publication of prospectus

Global Water Resources Declares Monthly Dividend

SUNation Energy Announces Initial Closing of Registered Direct Offering Generating Gross Proceeds of $15 Million

Company

Headlines

Black Hills Corp. Announces Upcoming Investor Meetings

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

Ultimovacs ASA: Approval and publication of prospectus

Global Water Resources Declares Monthly Dividend

Newsletter